Flaherty & Crumrine Preferred Income Opportunity Fund remains a buy, offering a 6.3% yield and trading at a 6.54% discount to NAV. PFO provides diversified exposure to preferred securities, with a ...
BASEL, Switzerland—In a study of Medicare fee-for-service beneficiaries older than 60 who had had an ischemic stroke, percutaneous patent foramen ovale (PFO) closure was associated with improved ...
There’s a good chance you may be walking around with a hole in your heart. “It’s as common as having blue eyes or being left-handed,” said Dr. Phillip Horwitz, a cardiologist and the executive ...
I rate PFO a buy due to its attractive discount to NAV and a compelling 6.6% dividend yield for income-focused investors. PFO's performance is highly sensitive to interest rates; future rate cuts ...
Current age-based restrictions on patent foramen ovale (PFO) closure should be reconsidered in light of observational data suggesting that carefully selected older patients fare as well as those who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results